🌐 fenebrutinib
Fenebrutinib is a Roche-developed investigational Bruton’s tyrosine kinase inhibitor monitored globally for clinical-trial progress, regulatory decisions, and potential use in autoimmune diseases.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| USC suspends LB for hit on Oregon's Dante Moore | expired | Health | responder | 100% |